Australia Markets close in 1 hr 42 mins

AdaptHealth Corp. (AHCO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
17.48+0.49 (+2.88%)
At close: 04:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close16.99
Open17.32
Bid15.15 x 3000
Ask18.00 x 4000
Day's range16.85 - 17.71
52-week range11.40 - 30.33
Volume1,114,460
Avg. volume1,185,663
Market cap2.311B
Beta (5Y monthly)0.40
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire

    AdaptHealth to Participate in UBS Global Healthcare Conference 2022

    PLYMOUTH MEETING, Pa., May 18, 2022--AdaptHealth Corp. (NASDAQ: AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that Josh Parnes, President and Director, and Jason Clemens, CFO, will participate in a fireside chat at the UBS Global Healthcare Conference 2022 on Wednesday, May 25, at 10:00 am ET.

  • Business Wire

    AdaptHealth to Participate in RBC Capital Markets 2022 Global Healthcare Conference

    PLYMOUTH MEETING, Pa., May 11, 2022--AdaptHealth Corp. (NASDAQ: AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that Josh Parnes, President, and Jason Clemens, CFO, will participate in a fireside chat at the RBC Capital Markets 2022 Global Healthcare Conference on Tuesday, May 17, at 10:30 am ET.

  • Business Wire

    AdaptHealth Reports First Quarter 2022 Results, Updates 2022 Guidance, and Announces $200 Million Share Repurchase Program

    PLYMOUTH MEETING, Pa., May 10, 2022--AdaptHealth Corp. (NASDAQ: AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financial results for the first quarter ended March 31, 2022, and announced the authorization of a share repurchase program for up to $200 million.